Public Education & Campaign Groups

The Association for Psychedelic Science and Therapy Austria connects mental health professionals and improves public awareness of safe, ethical, evidence-based psychedelic therapies.

Founded in 2020, the Autistic Psychedelic Community (APC) is a Los Angeles-based peer support and co-learning network focused on the intersection of psychedelics and neurodivergent conditions including autism and ADHD, offering psychedelic integration support, panel discussions with researchers, and academic partnerships. Cited in peer-reviewed research, the APC promotes neurodiversity-affirming approaches to psychedelic practice and safe access.

Policy-focused organization producing legislative analysis and implementation guidance on affordable, state-regulated psychedelic care pathways.

The Centre for Evidence Based Drug Policy is a UK think tank promoting evidence-based drug policy to reduce harm, improve public health, and unlock medical and economic benefits.

Cepda is a Danish non-profit think tank working on psychedelic education, community building, advocacy, and research collaboration among professionals, researchers, and people with lived experience.

Nonprofit platform focused on psychedelic education, cultural justice, and Indigenous reciprocity with programming at the intersection of ethics, policy, and community knowledge.

Grassroots campaign network focused on decriminalizing entheogenic plants and fungi through local policy campaigns, public education, and community organizing.

The European Federation of Neurological Associations (EFNA) is a Brussels-based umbrella organization representing 21 pan-European neurology patient groups, advocating for improved access and resources for people with neurological disorders. EFNA participates as a patient advocacy partner in the PsyPal consortium, the first EU-funded multi-site psilocybin clinical trial (€6.5M) studying psilocybin for psychological distress in palliative care neurological patients.

Fundación inawe is a Spanish non-profit promoting mental health innovation by developing an ecosystem for implementing psychedelic-assisted therapies in Spain.

The German Society for Psychedelic Research and Therapy is a professional association for physicians, psychologists, and other professionals supporting scientific work and potential clinical introduction of psychedelic therapies.

HYSTELICA is a non-profit researching, advocating, and educating for safe and effective psychedelic use for women, with a focus on ensuring women-specific needs shape the future of psychedelics.

Nonprofit campaign and implementation-support organization focused on expanding and protecting safe, affordable, state-regulated psychedelic therapy access, including Oregon and Colorado programs.

Veteran-serving nonprofit supporting access to psychedelic programs and advocating policy pathways that expand safe treatment options for veterans and their families.

HoloMind is a Polish initiative educating the public about therapeutic psychedelic use and advocating for psychedelic treatments in Poland.

Icelandic Psychedelic Society - Hugvikkandi is a platform for people interested in psychedelics to build community, strengthen advocacy, educate themselves, support research and legal progress, and collaborate internationally.

Irish Doctors for Psychedelic Assisted Therapy is a non-profit improving awareness of psychedelic research among clinicians and policymakers and advocating for state-funded psychedelic research trials.

SIMEPSI is an Italian multidisciplinary non-profit promoting psychedelic research, cultural awareness, regulatory frameworks for safe treatments, knowledge exchange, and public education.

Kykeon works to destigmatize psychedelics in Greece through community building, education, interdisciplinary dialogue on therapeutic use, and drug policy reform advocacy.

Luca Coscioni Association works with experts, researchers, and scientists to prepare technical documents supporting legislative, judiciary, and policy proposals and amendments.

MAPS Italia is a non-profit founded in 2024 to support informed dialogue, education, research, and advocacy for therapeutic uses of psychedelic substances in Italy.

The National Association for Psychedelic Research in Serbia promotes education, dialogue, and research advocacy around psychedelics in mental health, translating scientific findings for professionals and the public.

The Polish Psychedelic Society popularizes and supports scientific research on psychedelic substances and provides space for debate about their application in science, medicine, psychotherapy, and culture.

Psilocybin Access Rights is a volunteer campaign pressing the UK government to reschedule psilocybin and make it accessible for patients and researchers.

Salt City Psychedelic Therapy and Research (SCPTR) is a Utah-based nonprofit founded by the late Dr. Parth Gandhi to advance psychedelic-assisted therapy through education, research, and advocacy in the Intermountain West. SCPTR organizes the annual Intermountain Psychedelic Symposium and supports practitioners, researchers, and policy reform in the region.

SPACE is a Portuguese scientific association founded in 2021 by psychiatry doctors to study, disseminate, and promote knowledge about the potential therapeutic uses of psychedelic substances.

The Société Psychédélique Française is a French hub for young researchers, students, scientific and cultural mediation, and community discussion grounded in responsibility and harm reduction.

SEMPsi brings together medical doctors, psychologists, and mental health researchers to promote evidence-based psychedelic therapy and research in an ethical, scientific, and culturally respectful context.

Global youth-led network advocating evidence-based drug policy reform through campus organizing, policy campaigns, and public education that include psychedelic reform issues.

Veteran-focused nonprofit advocating expanded access to psychedelic-assisted therapies, especially for PTSD and related conditions, through policy engagement and public education.